NCT01033058View on ClinicalTrials.gov

Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI

PHASE4UnknownINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

June 30, 2011

Conditions
STEMI
Interventions
DRUG

atorvastatin

80mg atorvastatin immediately after enrollment, emergency PCI,atorvastatin 40mg/d and other usual medication after PCI

DRUG

atorvastatin

No loading dose of statin after enrollment, emergency PCI, atorvastatin 20mg/d and other usual medication after PCI

Trial Locations (1)

100020

Chaoyang Hospital, Beijing

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Beijing Chao Yang Hospital

OTHER